Nvidia's February 25 earnings report is shaping up as one of the most consequential market events of early 2026 — and for traders with exposure to the broader AI hardware ecosystem, the smart money may already be positioned in the supply chain well ahead of the print.
Several key semiconductor infrastructure plays have been quietly telegraphing sustained demand. Aehr Test Systems (NASDAQ: AEHR), which provides wafer-level burn-in and test equipment critical to AI chip production, issued a $60–80 million bookings forecast for fiscal 2026 — with the vast majority driven by AI wafer-level and packaged-part burn-in, not the silicon carbide segment that weighed on the stock in prior cycles. The company's lead Sonoma production customer — understood to be a major AI ASIC developer — has already placed substantial orders, with shipments expected to begin in Q1 FY2027 (starting May 2026).
That forward demand is meaningful context for Nvidia bulls. Burn-in and test equipment orders tend to lead actual chip production by one to three quarters, making Aehr's bookings pipeline a credible leading indicator for AI accelerator output volumes. The fact that Sonoma system orders in just the first six weeks of Q3 already exceeded all of Q2 suggests the pipeline is accelerating, not plateauing.
Credo Technology (NASDAQ: CRDO) adds another data point. The high-speed interconnect specialist — whose active electrical cables and line-card retimers are essential to hyperscale AI cluster networking — guided Q3 revenue of $335–345 million, a figure that would represent substantial sequential growth. Interconnect demand is a direct proxy for data center build density: as GPU clusters scale, so does the need for high-bandwidth, low-latency chip-to-chip and rack-to-rack connectivity. Credo's guidance effectively confirms that hyperscalers are still in aggressive build mode.
For traders, the interplay between Nvidia's own results and supplier signals creates a layered opportunity set. If Nvidia beats on data center revenue and raises forward guidance — the base case given the supplier data above — names like AEHR and CRDO could see sympathy moves. Conversely, any disappointment in Nvidia's outlook could compress multiples across the supply chain quickly, given that valuations in the AI hardware complex remain elevated relative to near-term earnings.
One structural risk worth pricing in: lead time constraints. Aehr's WaferPak production cycle runs approximately eight weeks, while the development of new High-Bandwidth Film (HBF) technology requires over a year. These aren't bottlenecks unique to Aehr — they reflect the broader reality that AI chip production scaling is still constrained by tooling and materials cycles. Any guidance from Nvidia that implies a faster-than-expected ramp could expose supply chain vendors to execution risk, even in a demand-positive environment.
The HBM3e memory layer adds further nuance. High-bandwidth memory remains a critical gating factor in next-generation AI accelerator performance, and any supply commentary from Nvidia on HBM availability — or constraints from SK Hynix and Samsung — could ripple across memory-adjacent test and packaging names.
The bottom line for traders: the semiconductor supply chain is sending a consistent bullish signal into Nvidia's print. Aehr's bookings trajectory and Credo's revenue guide both imply that downstream AI infrastructure spending has not peaked. But with execution risks embedded in lead times and valuations already reflecting a robust cycle, the asymmetry favors using any post-earnings dip in supply chain names as an accumulation opportunity rather than chasing the initial move.